TRXmeds closed a funding round (amount undisclosed) in Feb 2024. The company is based in Utrecht, Netherlands. Data as of 21 Sept 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
This is the company's only recorded round.
